Tokyo, Japan and London, UK, 26 January 2018 – Sosei Group Corporation (TSE Mothers Index: 4565) (“Sosei” or the “Company”), the world leader in GPCR medicine design and development, announced today it will hold its Investor Day from 10:00 a.m. JST on Wednesday, 14 March 2018 at the Hotel New Otani in Tokyo. Entry on the day will commence from 09:30 a.m.
The Investor Day will be held in the Fuyo Room at the Hotel New Otani and hosted by members of Sosei’s senior management team, with a keynote presentation from Dr. Richard Henderson, co-founder of Heptares Therapeutics and 2017 Nobel Prize winner in Chemistry for his pioneering work in the field of cryo-electron microscopy. Sosei will provide an update on its corporate strategy as well as insight to its GPCR structural design approach and pipeline programs, including HTL0018318, its wholly-owned Phase 2 ready candidate for dementia with Lewy bodies (DLB) in Japan.
Invitation cards will be sent out via mail today to all shareholders on the register as of 31 December 2017. RSVP is required for in-person attendance at the Investor Day, so please ensure you return the required section of your invitation card by no later than the close of business on Friday, 16 February 2018. Shareholders are also reminded to please bring the remainder of their invitation cards on the day of the event to present at the front registration desk.